Philab to Acquire Sydenham Laboratories

Philab Holdings Corp. (PSE: DNA) has confirmed its plans to acquire 67 percent of local pharmaceutical firm Sydenham Laboratories Inc. (SLI). This proposed acquisition is still subject to the results of due diligence and regulatory approvals from the Securities and Exchange Commission (SEC) and the Philippine Stock Exchange (PSE). With more than 40 years in […]
Continue reading…